Dr. Harish G. Ahuja
Claim this profileAspirus Regional Cancer Center
Expert in Cancer
Expert in Lung Cancer
37 reported clinical trials
86 drugs studied
About Harish G. Ahuja
Education:
- Obtained a Medical degree (MD) from the University of Wisconsin School of Medicine and Public Health.
- Completed Residency in Radiation Oncology at the University of Wisconsin Hospital and Clinics.
- Undertook a Fellowship in Stereotactic Radiosurgery and Brachytherapy at the same institution.
Experience:
- Currently serves as a Radiation Oncologist at Aspirus Regional Cancer Center.
Area of expertise
1Cancer
Global LeaderStage III
Stage IV
Stage II
2Lung Cancer
Global LeaderStage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Harish G. Ahuja is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Harish G. Ahuja
Clinical Trial Related5 years of experience running clinical trials · Led 37 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Harish G. Ahuja has experience with
- Atezolizumab
- Carboplatin
- Fluorouracil
- Paclitaxel
- Pembrolizumab
- Cisplatin
Breakdown of trials Harish G. Ahuja has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Harish G. Ahuja specialize in?
Harish G. Ahuja focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is Harish G. Ahuja currently recruiting for clinical trials?
Yes, Harish G. Ahuja is currently recruiting for 14 clinical trials in Wausau Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Harish G. Ahuja has studied deeply?
Yes, Harish G. Ahuja has studied treatments such as Atezolizumab, Carboplatin, Fluorouracil.
What is the best way to schedule an appointment with Harish G. Ahuja?
Apply for one of the trials that Harish G. Ahuja is conducting.
What is the office address of Harish G. Ahuja?
The office of Harish G. Ahuja is located at: Aspirus Regional Cancer Center, Wausau, Wisconsin 54401 United States. This is the address for their practice at the Aspirus Regional Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.